These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 12359122)

  • 1. Benefit and risk management for steroid treatment in upper airway diseases.
    Krahnke J; Skoner D
    Curr Allergy Asthma Rep; 2002 Nov; 2(6):507-12. PubMed ID: 12359122
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Local and systemic safety of intranasal corticosteroids.
    Sastre J; Mosges R
    J Investig Allergol Clin Immunol; 2012; 22(1):1-12. PubMed ID: 22448448
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pharmacokinetics of intranasal corticosteroids.
    Szefler SJ
    J Allergy Clin Immunol; 2001 Jul; 108(1 Suppl):S26-31. PubMed ID: 11449203
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Relationship between systemic corticosteroid exposure and growth velocity: development and validation of a pharmacokinetic/pharmacodynamic model.
    Daley-Yates PT; Richards DH
    Clin Ther; 2004 Nov; 26(11):1905-19. PubMed ID: 15639702
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Safety of intranasal corticosteroid sprays during pregnancy: an updated review.
    Alhussien AH; Alhedaithy RA; Alsaleh SA
    Eur Arch Otorhinolaryngol; 2018 Feb; 275(2):325-333. PubMed ID: 29164323
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Intranasal corticosteroids for allergic rhinitis.
    Trangsrud AJ; Whitaker AL; Small RE
    Pharmacotherapy; 2002 Nov; 22(11):1458-67. PubMed ID: 12432972
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Intranasal fluticasone propionate. A reappraisal of its pharmacology and clinical efficacy in the treatment of rhinitis.
    Wiseman LR; Benfield P
    Drugs; 1997 May; 53(5):885-907. PubMed ID: 9129872
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Safety of intranasal corticosteroids.
    Bensch GW
    Ann Allergy Asthma Immunol; 2016 Dec; 117(6):601-605. PubMed ID: 27979016
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Fluticasone propionate aqueous nasal spray in the treatment of nasal polyposis.
    Holmberg K; Juliusson S; Balder B; Smith DL; Richards DH; Karlsson G
    Ann Allergy Asthma Immunol; 1997 Mar; 78(3):270-6. PubMed ID: 9087151
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Topical corticosteroids in nasal polyposis.
    Badia L; Lund V
    Drugs; 2001; 61(5):573-8. PubMed ID: 11368283
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Lack of long-term add-on effect by montelukast in postoperative chronic rhinosinusitis patients with nasal polyps.
    Van Gerven L; Langdon C; Cordero A; Cardelús S; Mullol J; Alobid I
    Laryngoscope; 2018 Aug; 128(8):1743-1751. PubMed ID: 29114894
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Safety of inhaled and intranasal corticosteroids: lessons for the new millennium.
    Lipworth BJ; Jackson CM
    Drug Saf; 2000 Jul; 23(1):11-33. PubMed ID: 10915030
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Impact of intranasal corticosteroids on asthma outcomes in allergic rhinitis: a meta-analysis.
    Lohia S; Schlosser RJ; Soler ZM
    Allergy; 2013; 68(5):569-79. PubMed ID: 23590215
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Advances in the medical treatment of nasal polyps.
    Mygind N
    Allergy; 1999; 54 Suppl 53():12-6. PubMed ID: 10442545
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Molecular and clinical pharmacology of intranasal corticosteroids: clinical and therapeutic implications.
    Derendorf H; Meltzer EO
    Allergy; 2008 Oct; 63(10):1292-300. PubMed ID: 18782107
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Intranasal Corticosteroids Do Not Lead to Ocular Changes: A Systematic Review and Meta-analysis.
    Valenzuela CV; Liu JC; Vila PM; Simon L; Doering M; Lieu JEC
    Laryngoscope; 2019 Jan; 129(1):6-12. PubMed ID: 30229924
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mode of action of intranasal corticosteroids.
    Mygind N; Nielsen LP; Hoffmann HJ; Shukla A; Blumberga G; Dahl R; Jacobi H
    J Allergy Clin Immunol; 2001 Jul; 108(1 Suppl):S16-25. PubMed ID: 11449202
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hypothalamic-pituitary-adrenal axis suppression and intranasal corticosteroid use: A systematic review and meta-analysis.
    Sampieri G; Namavarian A; Lee JJW; Hamour AF; Lee JM
    Int Forum Allergy Rhinol; 2022 Jan; 12(1):11-27. PubMed ID: 34260153
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Intranasal spray medications for maintenance therapy of allergic rhinitis.
    Berger WE; Meltzer EO
    Am J Rhinol Allergy; 2015; 29(4):273-82. PubMed ID: 26132312
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A review of the preclinical and clinical data of newer intranasal steroids used in the treatment of allergic rhinitis.
    Lumry WR
    J Allergy Clin Immunol; 1999 Oct; 104(4 Pt 1):S150-8. PubMed ID: 10518812
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.